Li J - Search Results

1

Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma.

Xia S, Chen L, Yu M, Li J, Chen J, Xu F, Ni M, Liu C, Wu X, Chen X, Li J. Xia S, et al. Among authors: li j. J Immunother Cancer. 2024 Nov 27;12(11):e010069. doi: 10.1136/jitc-2024-010069. J Immunother Cancer. 2024. PMID: 39608974 Free PMC article.

2

FBW7 suppresses ovarian cancer development by targeting the N⁶-methyladenosine binding protein YTHDF2.

Xu F, Li J, Ni M, Cheng J, Zhao H, Wang S, Zhou X, Wu X. Xu F, et al. Among authors: li j. Mol Cancer. 2021 Mar 3;20(1):45. doi: 10.1186/s12943-021-01340-8. Mol Cancer. 2021. PMID: 33658012 Free PMC article.

3

Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma.

Hao Q, Li J, Zhang Q, Xu F, Xie B, Lu H, Wu X, Zhou X. Hao Q, et al. Among authors: li j. Clin Transl Med. 2021 Aug;11(8):e500. doi: 10.1002/ctm2.500. Clin Transl Med. 2021. PMID: 34459128 Free PMC article.

4

PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer.

Liu C, Li J, Xu F, Chen L, Ni M, Wu J, Zhao H, Wu Y, Li J, Wu X, Chen X. Liu C, et al. Among authors: li j. Mol Cancer. 2024 May 22;23(1):111. doi: 10.1186/s12943-024-02025-8. Mol Cancer. 2024. PMID: 38778348 Free PMC article.

5

Circ0004390 promotes cell proliferation through sponging miR-198 in ovarian cancer.

Xu F, Ni M, Li J, Cheng J, Zhao H, Zhao J, Huang S, Wu X. Xu F, et al. Among authors: li j. Biochem Biophys Res Commun. 2020 May 21;526(1):14-20. doi: 10.1016/j.bbrc.2020.03.024. Epub 2020 Mar 17. Biochem Biophys Res Commun. 2020. PMID: 32192774 Free article.

6

A Population-Based Study on Liver Metastases in Women With Newly Diagnosed Ovarian Cancer.

Zhao H, Xu F, Li J, Ni M, Wu X. Zhao H, et al. Among authors: li j. Front Oncol. 2020 Sep 25;10:571671. doi: 10.3389/fonc.2020.571671. eCollection 2020. Front Oncol. 2020. PMID: 33102229 Free PMC article.

7

BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.

Ni M, Li J, Zhao H, Xu F, Cheng J, Yu M, Ke G, Wu X. Ni M, et al. Among authors: li j. Oncogene. 2021 Apr;40(15):2711-2724. doi: 10.1038/s41388-021-01735-3. Epub 2021 Mar 12. Oncogene. 2021. PMID: 33712705

8

NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.

Yu M, Ni M, Xu F, Liu C, Chen L, Li J, Xia S, Diao Y, Chen J, Zhu J, Wu X, Tang M, Li J, Ke G. Yu M, et al. Among authors: li j. Mol Cancer. 2024 Jul 5;23(1):139. doi: 10.1186/s12943-024-02055-2. Mol Cancer. 2024. PMID: 38970106 Free PMC article.

9

Identification of Somatic Genetic Alterations Using Whole-Exome Sequencing of Uterine Leiomyosarcoma Tumors.

Chen L, Li J, Wu X, Zheng Z. Chen L, et al. Among authors: li j. Front Oncol. 2021 Jun 11;11:687899. doi: 10.3389/fonc.2021.687899. eCollection 2021. Front Oncol. 2021. PMID: 34178683 Free PMC article.

10

Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin β5-mediated glycolysis.

Wang S, Xie J, Li J, Liu F, Wu X, Wang Z. Wang S, et al. Among authors: li j. Am J Cancer Res. 2016 May 1;6(5):1108-17. eCollection 2016. Am J Cancer Res. 2016. PMID: 27294003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192,363 results

Search Page

Filters